We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Integra LifeSciences
IART
$1.54B
| $217K | ﹤0.01% |
5,129
+29
| +0.6% | +$1.49K |
|
1352
Louisiana-Pacific
LPX
$5.2B
| $217K | ﹤0.01% |
4,241
-517
| -11% | -$29.4K |
|
1353
PagerDuty
PD
$700M
| $217K | ﹤0.01% |
9,380
-180
| -2% | -$4.65K |
|
1354
Tandem Diabetes Care
TNDM
$1.17B
| $217K | ﹤0.01% |
4,532
-28
| -0.6% | -$1.53K |
|
|
XHR
1355
Xenia Hotels & Resorts
XHR
$1.98B
| $217K | ﹤0.01% |
15,723
-409
| -3% | -$6.53K |
|
1356
Zentalis Pharmaceuticals
ZNTL
$308M
| $217K | ﹤0.01% |
9,968
+1,230
| +14% | +$33.6K |
|
|
UNVR
1357
DELISTED
Univar Solutions Inc.
UNVR
| $217K | ﹤0.01% |
9,575
-231
| -2% | -$5.8K |
|
1358
Vicor
VICR
$9.62B
| $216K | ﹤0.01% |
3,643
-16
| -0.4% | -$1.06K |
|
|
MDC
1359
DELISTED
M.D.C. Holdings, Inc.
MDC
| $216K | ﹤0.01% |
7,856
-203
| -3% | -$6.72K |
|
1360
Green Plains
GPRE
$1.19B
| $215K | ﹤0.01% |
7,395
-71
| -1% | -$2.4K |
|
1361
Herbalife
HLF
$1.23B
| $215K | ﹤0.01% |
10,798
-517
| -5% | -$12.8K |
|
1362
Jack in the Box
JACK
$278M
| $215K | ﹤0.01% |
+2,907
| New | +$220K |
|
1363
Stock Yards Bancorp
SYBT
$2.41B
| $215K | ﹤0.01% |
+3,157
| New | +$211K |
|
1364
Thor Industries
THO
$3.99B
| $214K | ﹤0.01% |
3,070
-62
| -2% | -$5.07K |
|
|
AKRO
1365
DELISTED
Akero Therapeutics
AKRO
| $213K | ﹤0.01% |
+6,249
| New | +$95.6K |
|
1366
ICU Medical
ICUI
$3.93B
| $213K | ﹤0.01% |
1,415
-17
| -1% | -$2.83K |
|
1367
ImmunityBio
IBRX
$7.44B
| $212K | ﹤0.01% |
42,697
+2,510
| +6% | +$11.4K |
|
1368
Stem
STEM
$49.2M
| $212K | ﹤0.01% |
794
-16
| -2% | -$4.09K |
|
1369
Urban Edge Properties
UE
$2.94B
| $212K | ﹤0.01% |
15,812
-209
| -1% | -$3.26K |
|
|
FTCH
1370
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $212K | ﹤0.01% |
28,448
-79,877
| -74% | -$709K |
|
1371
Delek US
DK
$3.87B
| $211K | ﹤0.01% |
7,771
-148
| -2% | -$3.91K |
|
|
ELME
1372
Elme Communities
ELME
$132M
| $211K | ﹤0.01% |
12,019
-310
| -3% | -$6.34K |
|
1373
TechnipFMC
FTI
$30.6B
| $211K | ﹤0.01% |
24,897
+543
| +2% | +$4.28K |
|
1374
United Parks & Resorts
PRKS
$2.11B
| $211K | ﹤0.01% |
4,637
-441
| -9% | -$21.9K |
|
|
KDNY
1375
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $211K | ﹤0.01% |
+10,788
| New | +$216K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.